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Abstract
Purinergic receptors participate, in almost every cell type, in controlling metabolic activities and many physiological
functions including signal transmission, proliferation and differentiation. While most of P2Y receptors induce
transient elevations of intracellular calcium concentration by activation of intracellular calcium pools and forward
these signals as waves which can also be transmitted into neighboring cells, P2X receptors produce calcium spikes
which also include activation of voltage-operating calcium channels. P2Y and P2X receptors induce calcium
transients that activate transcription factors responsible for the progress of differentiation through mediators
including calmodulin and calcineurin. Expression of P2X2 as well as of P2X7 receptors increases in differentiating
neurons and glial cells, respectively. Gene expression silencing assays indicate that these receptors are important for
the progress of differentiation and neuronal or glial fate determination. Metabotropic receptors, mostly P2Y1 and
P2Y2 subtypes, act on embryonic cells or cells at the neural progenitor stage by inducing proliferation as well as by
regulation of neural differentiation through NFAT translocation. The scope of this review is to discuss the roles of
purinergic receptor-induced calcium spike and wave activity and its codification in neurodevelopmental and
neurodifferentiation processes.
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The importance of establishing cellular replacement
therapies is increasing nowadays. These therapies are
based on stem cells due to their capability of originating
other cell types by differentiation, or even releasing
factors that can reduce inflammatory responses and pro-
mote homing of adult stem cells of the proper patient to
the site of injury. However, the molecular mechanisms
of development, cell differentiation, successful cell en-
graftment and recruitment of endogenous stem cells in
case of injury need yet to be resolved. Thus, major
efforts are being undertaken in order to understand the
process of neural differentiation, mediated by intracellu-
lar signaling triggered by external and internal stimuli,
resulting in differential gene transcription pattern and
neural phenotype determination.
Intracellular calcium signaling and purinergic
receptors
Among different pathways coordinating intracellular sig-
naling, the most prominent is intracellular calcium sig-
naling (ICS), controlling various cellular processes
including proliferation, motility, apoptosis and differenti-
ation [1]. ICS is impressively diverse and consists of
mechanisms that differ in frequency, amplitude and
spatio-temporal patterning depending on an extensive
molecular repertoire of signaling components. The free
intracellular calcium concentration ([Ca2+]i) of a resting
cell is in the range of 10–100 nM. Following physiological
stimulation, [Ca2+]i levels can rise up to 1-2 μM
concentrations. ICS is codified by the peak amplitude
and frequency of [Ca2+]i transients, promoted by the
entry of external Ca2+ through Ca2+ channels or the re-
lease of Ca2+ from internal stores. These internal stores
are deposited within internal membrane structures such
as the endoplasmic reticulum (ER). Following activation
of G-protein-coupled receptors, phospholipase C-β
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(PLC-β) cleaves phosphatidylinositol 4,5-bisphosphate,
releasing diacylglycerol and inositol-1,4,5-trisphosphate
(IP3) which diffuses into the cell for activation of IP3
receptors (IP3R) and releasing Ca2+ from the ER. More-
over, Ca2+ enters the cytosol and activates ryanodine
receptor (RYR) channels following activation of voltage-
operated channels (VOCs), or receptor-operated chan-
nels (ROCs); this process is called Ca2+-induced Ca2+
release [2-4].
There are mainly two types of spontaneous intracellu-
lar Ca2+ transients: waves and spikes. The first one is
mediated by IP3R and/or RYR activation and involves
sensitivity to [Ca2+]i levels. This Ca
2+ entry pathway is
active at resting potential and is amplified by Ca2+ re-
lease from intracellular stores, and increases [Ca2+]i to a
lower level than that attained by spikes. In the presence
of gap junctions connecting cells, these intracellular
waves can spread to neighboring cells, thereby coordin-
ating neural activity and physiological processes of many
cells [5,6]. Compared to Ca2+ spikes, waves reveal a
lower frequency with a mean duration of more than 30s,
as observed in growth cones; their generation does not
depend on action potentials. Waves occur locally and
decay with distance from the site of initiation.
Calcium spikes depend on Ca2+ influx through VOCs
or ROCs and Ca2+ release from intracellular stores (Ca2+
induced Ca2+ release via RYR), and achieve mean [Ca2+]i
levels of 500 nM. They are characterized by their frequency
(mean duration approximately 10s), and occur throughout
an excitable cell, since they involve Ca2+-dependent action
potentials.
Spontaneous Ca2+ spike frequency in cultured neurons
initially varies from 1-10/h and then declines. Similar
patterns of spike activity were observed in neural tube
stages in vivo [2,7] and during neuronal differentiation
of embryonal carcinoma (CSC, a model for pluripotent
embryonic stem cells) and adult bone marrow me-
senchymal (hMSC) stem cells [8,9]. Notably, these low
frequencies of calcium transients regulate gene tran-
scription and are suggested to be essential for the
progress of neural differentiation and phenotype specifi-
cation [2,10-12].
Chemical and electrical signals, mediated by meta-
botropic and ionotropic receptors and VOCs promote
intracellular calcium signaling and subsequent induction
of differentiation. Adenosine 5’-triphosphate (ATP)-
activated metabotropic and ionotropic receptors, also
denominated as purinergic receptors, have drawn a lot
of attention, due to their wide expression in almost every
cell including stem cells. These receptors belong to the
first neurotransmitter receptors expressed during devel-
opment [13,14]. ATP is the mainly purinergic messenger
molecule and is released from cells in physiological
conditions by exocytosis, transporters or even lysosomes.
When the release occurs by damaged cells in an uncon-
trolled manner, ATP contributes to cell death and dis-
ease states. Once released into the extracellular space,
ATP is degraded by ectonucleotidases producing the sig-
naling molecules adenosine diphosphate (ADP), adeno-
sine monophosphate [15] and adenosine [14]. Based on
pharmacological and structural properties, purinergic
receptors are divided into metabotropic P1 and P2Y
receptors as well as P2X ionotropic receptors.
P1 receptors subtypes are selective for adenosine and
are classical seven-transmembrane metabotropic receptors
coupled to several families of Gi, Go and Gs proteins.
There are four types of adenosine receptors (A1, A2A,
A2B and A3) differing by pharmacological and functional
properties [15]. A1 and A3 receptors exert inhibitory
effects on adenylyl cyclase activity (mediated through Gi/o
proteins) and also regulate PLC-β activity and thus IP3
synthesis [14]. P2 receptor subtypes are activated by ATP,
ADP, uridine-5'-triphosphate (UTP), uridine-5'-diphos-
phate (UDP) or UDP-glucose. P2 receptors are further
divided into P2X and P2Y subtypes based on their struc-
tural characteristics [13].
P2X receptors as ATP-gated cationic (Na+/K+/Ca2+)
channels [13,16], are assembled in trimeric form as
homomeric or heteromeric receptors from seven
subunits (P2X1-P2X7). Recombinant P2X1, P2X2, P2X3,
P2X4, P2X2/3, P2X2/6, P2X4/6, P2X1/5 as well as P2X7
receptors, when activated in a silent environment of cells
not expressing any endogenous purinergic receptor, were
all shown to be permeable for Ca2+ [17]. P2X receptors
are mostly expressed by excitable cells, and Ca2+ entry
through P2X receptor channels provides an important
regulation mechanism of physiological responses in vivo,
while aberrant Ca2+ entry, mostly mediated by P2X7
receptors, is suggested to be involved in pathophysio-
logical conditions such as cell death, neuroinflammation
and excitotoxic brain damage during epilepsy [18-22].
Metabotropic P2Y purinergic receptors activated by
ATP, ADP, UTP, UDP or UDP glucose are composed by
P2Y1,2,4,6,11,12,13,14 subtypes based on phylogenetic
similarity [14]. P2Y1,2,4,6,11 subtypes are coupled to
Gq/G11 proteins activating PLC-β, thus inducing IP3-
mediated Ca2+ release from the ER [13,14,23]. P2Y12,13,14
receptors inhibit adenylyl cyclase activity via Gi/o proteins.
These latter-mentioned receptors also participate in regu-
lating [Ca2+]i levels. For instance, P2Y receptor subtypes
acting via Gi/o proteins can regulate N-type Ca2+ channel
activity [24-26]. P2Y receptors are expressed in the central
and autonomic nervous systems as well as by most non-
excitatory cells where they exert long-term effects by regu-
lating crucial cellular functions including proliferation and
differentiation [14].
Recent studies have focused on changes of expression
patterns and functions of this receptor family during
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differentiation from embryonic into neuronal cells
[8,27]. The developmental fate of differentiating stem
cells depends on the ‘niche’, in which the cells exist, and
several associated signaling systems have been
pinpointed [28,29]. In this review, we discuss the import-
ance of ICS for the differentiation process of stem cells
into neural cells with special emphasis on purinergic re-
ceptor function during Ca2+ signaling.
Purinergic receptors triggering ICS in the nervous
system and neural differentiation
Many of the signal transduction pathways that control
cell metabolism, survival and differentiation are activated
by elevation of [Ca2+]i levels following activation of
purinergic receptors. Moreover, numerous experimental
data point at essential functions of purinergic signaling
in neural differentiation and brain development. It has
been well established that purinergic receptor activation
triggers [Ca2+]i transients that are involved in develop-
mental processes of the embryo [30,31]. Pioneering stud-
ies of Nicholas Spitzer that the progress of neurogenesis
and phenotype determination, such as neurotransmitter
specification, is encoded by naturally occurring patterns
of [Ca2+]i transients, are in agreement with essential
functions of purinergic receptor signaling for cortex de-
velopment. As detailed above, P2X receptors by inducing
Ca2+ influx generate repetitive [Ca2+]i transients in spike
form with activation of RYR while P2Y receptors act
through IP3-induced intracellular Ca2+ release which
then is propagated in wave form (Figure 1).
Ionotropic purinergic receptors also participate in
regulation of neural proliferation and neurogenesis by
inducing calcium spikes. In agreement, P2X2 and P2X6
receptor subunit expression was enhanced together with
the enrichment of neurons during differentiation of rat
embryonic telencephalon [32]. For instance, P2X recep-
tor activity is suggested to be involved in hippocampal
neurogenesis by inducing proliferation of hippocampal
progenitor cells [33]. The P2X7 receptor usually partici-
pates in pore formation, but its abundant presence in
synaptic structure suggests a role in synaptic plasticity
establishment [26]. Some experimental data indicate that
P2X7 receptors, rather than connexin-hemichannels,
mediate ATP release and amplification of astrocytic
intercellular Ca2+ signaling [34]. In view of that, it will
be worth to study the participation of P2X7 receptors in
Figure 1 Oscillations of [Ca2+]i levels and purinergic receptors. Ionotropic P2X receptors trigger calcium spikes characterized by amplitudes
and frequency (A), while metabotropic P2Y receptors induce calcium waves with lower amplitudes and frequencies (B). P2X receptors are
composed of three subunits, with two transmembrane loops each. G protein-coupled metabotropic P2Y receptors are composed of 7
transmembrane loops.
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directing of migration and neurogenesis, such as shown
for P2Y1 receptors in radial glial cells during cortex de-
velopment [6].
Ionotropic purinergic receptors were also involved in
the progress of pluripotent P19 CSC differentiation and
neural phenotype determination. Functions of P2X2 and
P2X7 receptor subtypes in conditions of down-regulation
of receptor gene expression were studied by stable RNA
interference. Knock-down of P2X2 receptor expression
along neural differentiation resulted in diminished expres-
sion of β-3-tubulin expression indicating interference with
the progress of neurogenesis. On the other hand, P2X7
receptor expression and activity was related to induction
of proliferation and gliogenesis, since permanent P2X7
receptor RNA interference resulted in reduced 5’-bromo-
2'-deoxyuridine (BrdU) incorporation and glial fibrillary
acidic (GFAP) protein expression [35] (see Figure 2 for a
comprehensive scheme of metabotropic and ionotropic
purinergic receptor implication in proliferation and differ-
entiation induction of P19 CSC).
Our laboratory has shown that a full-length and an al-
ternatively spliced form of the mouse P2X6 receptor
gene are expressed in mouse P19 CSC, an in vitro model
for early neuroectodermal differentiation. The truncated
alternatively spliced form was present at the undif-
ferentiated stage of P19 CSC, and was predominant
compared to the full-length form during the whole
course of neuronal differentiation of these cells [37]
suggesting that splicing could provide a mechanism
for regulation of P2X6 subunit expression and forma-
tion of functional P2X receptors with P2X6 subunit
contribution.
The involvement of these receptors in ATP-induced
[Ca2+]i transients was probed in pharmacological studies.
Moreover, embryonic P19 CSC expressed various other
functional subtypes including P2Y1, P2Y2 and P2X4 re-
ceptors or P2X-heteromultimeric receptors. In neuronal-
differentiated cells, P2Y2, P2Y6, P2X2 and possibly P2X2/
P2X6 heteromeric receptors were the major mediators of
purinergic receptor-mediated [Ca2+]i elevations.
Figure 2 Functions of P2X and P2Y receptor subtypes in stem cell biology. P2Y1 and P2Y2 receptors regulate proliferation of pluripotent
stem cells such as studied using P19 embryonal carcinoma cells as in vitro model. P2Y2 and P2Y1 receptors promote proliferation and neural
differentiation of pluripotent and neural progenitor cells. P2Y2, P2X2 and P2X7 receptors participate in later differentiation and neural phenotype
determination. P2X2 and P2X7 receptor expression/activity levels provide a further switch for neuronal or glial fate of P19 cell differentiation.
Arrows indicate increases or decreases in receptor expression and activity levels in respective stages of differentiation [36].
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P2Y1 receptor activation produces [Ca2+]i transients
which are then propagated in wave form through
neighbouring cells by gap junctions and connexin 43-
hemichannels resulting in cell cycle synchronization of
migrating neural progenitors and radial glia cells in the
subventricular zone for cortex development [6]. ATP has
also been shown to induce proliferation of human neural
stem cells (NSC) cultured from telencephalon tissues
from a 15-week gestational age embryo [38]. P2Y1 recep-
tor-mediated [Ca2+]i transients resulted in Ca
2+/calmo-
dulin (CAM)-dependent protein kinase II (CaMKII)
activation in cell soma and neurites of cerebellar granule
neurons, followed by cAMP/Ca2+ response element bind-
ing protein (CREB) phosphorylation and modulation of
gene transcription [39]. Neurotrophic effects, such as
observed in Neuro2A cells, were induced by P2Y1 recep-
tor signaling [40]. Here, low-frequency global and local
Ca2+ transients induced by purinergic receptor activation
during early stages of differentiation of neural progenitor
cells promoted neurite outgrowth and the onset of
GABAergic neurotransmitter phenotype specification. Sur-
prisingly, spontaneous Ca2+ signals in individual precursors
were not synchronized with Ca2+ transients in surrounding
cells, indicating the existence of a different pathway,
not depending on connexin 43-hemichannel-mediated
intercellular Ca2+ signaling [41].
Calcium ions also plays an important role in
proliferation and differentiation of hMSCs. Spontaneous
[Ca2+]i oscillations occur without agonist stimulation in
hMSCs. These [Ca2+]i transient are mediated by IP3-
induced Ca2+ release and controlled by an autocrine/
paracrine signaling pathway in which ATP is secreted via
a hemi-gap junction channel and then stimulates the
P2Y1 receptor, resulting in the activation of PLC-β for
IP3 production. Furthermore, [Ca2+]i oscillations are
associated with nuclear factor of activated T-cell (NFAT)
translocation into the nucleus of undifferentiated
hMSCs, providing a new role for [Ca2+]i oscillations in
such stem cells [42].
The P2Y2 receptor subtype, another purinergic recep-
tor involved in neural differentiation, which activates of
PLC-β, intracellular Ca2+ release and intercellular Ca2+
waves, important for embryonic development [43]. How-
ever in neural stem cells, Lin and coworkers [44] described
that neural progenitor proliferation is modulated by an
autocrine loop. These cells release ATP and thus activate
P2Y receptors for proliferation maintenance. Blockade of
proliferation and induction to neural differentiation oc-
curred only when purinergic receptor activity had been
antagonized and [Ca2+]i transients had diminished.
In undifferentiated P19 CSC, ATP provoked acceler-
ation of proliferation via P2Y1 and P2Y2 receptor activa-
tion. P19 CSC that progressed to the progenitor stage
revealed down-regulated P2Y1 receptor expression,
while activation of IP3-sensitive intracellular Ca2+ stores
was mediated by P2Y2 receptors. The progress of neur-
onal differentiation and phenotype transition was
determined by analysis of nestin and neuron-specific
enolase gene and protein expression levels [27,45].
Activation of transcription factors by ICS
It is important to highlight that during differentiation
many immediate early genes are activated in order to
regulate cell’s genomic responses to environmental stim-
uli. Underlying intracellular mechanisms are not clear
yet; however, Sheng and coworkers showed that c-fos ex-
pression, an immediate early gene, depends on calcium
influx. This increase activates the calcium response
element (CaRE) and thus results in phosphorylation/ac-
tivation of the CaRE binding protein and consequently
c-fos transcription [46].
The transcription factor CREB is activated in neurons
in response to trans-synaptic signaling and regulates the
expression of genes important for adaptive neuronal
responses, such as behavioral adaptation to changes in
the environment [47], as well as for more complex
neural functions, such as learning and memory forma-
tion [48]. Target genes include immediate early genes,
such as c-fos [46], and molecules essential for synaptic
function, including brain derived neurotrophic factor
(BDNF) [49,50] and neuronal nitric oxide synthase
(nNOS) [51]. In addition to its functions in mature
neurons, CREB regulates cell proliferation, differenti-
ation, and survival responses in a range of cell types in
developing vertebrates [52-54]. CREB is inactive as a
transcription factor until a cell is exposed to any one of
a range of extracellular stimuli that trigger CREB phos-
phorylation at a specific site. Ser133 within its kinase-
inducible domain promotes association of CREB with a
co-adaptor protein, the CREB binding protein (CBP).
The recruitment of CBP by CREB to the promoter of a
CREB target gene then induces the assembly of an active
polymerase II transcription complex, thus leading to tar-
get gene activation [55]. The kinetics of CREB Ser142
and Ser143 phosphorylation suggest that, when both of
these phosphorylation events occur together with Ser133
phosphorylation, they promote CREB activation [56].
Moreover, experimental evidence indicates that Ca2+/
CaM dependent kinase IV (CaMKIV) and CREB play a
critical role in mediating calcium-induced dendritic
growth in cortical neurons. A constitutively active form of
CaMKIV induces dendritic growth in the absence of
extracellular stimulation and activates the transcription
factor CREB [57].
In hippocampal neurons, signaling to CREB activation
can be triggered by elevations in nuclear calcium concen-
tration alone and does not require import of cytoplasmic
proteins into the nucleus. The nucleus is particularly
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suited to integrate neuronal firing patterns, and specifies
the transcriptional outputs through a burst frequency and
nuclear calcium amplitude conversion. Calcium release
from intracellular stores promotes calcium wave propaga-
tion into the nucleus, which is critical for CREB-mediated
transcription by synaptic receptors. Pharmacological mo-
dulation of nuclear calcium or modulation of gene ex-
pression levels of proteins involved in this process may
directly affect stem cell differentiation during develop-
ment [58].
Another important regulatory molecule that is sensible
to changes in [Ca2+]i is the transcription factor myocyte
enhancer factor-2 (MEF2), which is highly expressed in
neurons and during embryogenesis. Experimental evi-
dence indicates roles for MEF2 as a calcium-dependent
regulator of neuronal differentiation and function. The
calcium-binding protein CaM is activated by signals that
trigger rises in [Ca2+]i resulting in Ca
2+-bound CaM
association with calcineurin (Cn), and thus releases Cn
from its repressive effects. Cn dephosphorylates NFAT
and MEF2, allowing them to translocate into the nucleus
and consequently switch on gene transcription [59].
When Ca2+ entry is prevented or Cn activity is inhibited,
NFAT is rephosphorylated by NFAT kinases and rapidly
leaves the nucleus (t1/2 ∼ 15 min), and NFAT-dependent
gene expression is terminated [60-63]. As a result of this
absolute dependence on Ca2+/Cn signaling, NFAT has a
remarkable ability to sense dynamic changes in intracel-
lular Ca2+ levels and frequencies of Ca2+ oscillations in
cells [64] (Figure 3). Furthermore, activation of CaMKII,
through high-amplitude calcium spikes [65], induces
neural gene expression through transcription factors of
the MEF2 family [59].
Gene expression induced by [Ca2+]i transients, tri-
ggered by activation of VOCs and [66] and purinergic
P2X or P2Y receptors, could comprise general regulation
Figure 3 P2X and P2Y receptor-mediated calcium signal transduction for neural differentiation and proliferation. Activation of
ionotropic P2X and metabotropic P2Y receptors trigger increases of [Ca2+]i by promoting influx of extracellular calcium or by endoplasmatic
reticulum calcium release, respectively. These [Ca2+]i transients induce neural gene expression, by activation of some kinases or phosphatases
which then stimulate transcription factors such as CREB, MEF2 and NFAT. Abbreviations: IP3, inositol 1,4,5-trisphosphate. RYR, ryanodine receptor.
Gq, Gq protein. PLCβ, phospholipase C-β. PIP2, phosphatidylinositol 4,5-bisphosphate. DAG, diacylglycerol. IP3R, IP3 receptor. CaMK, Ca2+/calmodulin-
dependent protein kinase. CREB, cAMP/Ca2+ response-binding element. CBP, CREB-binding protein. MEF2, myocyte enhancer factor-2. NFAT, nuclear
factor of activated T-cells. PKC, protein kinase C. CaM, calmodulin. Caln, calcineurin.
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mechanisms of neural differentiation. Such hypothesis is
in agreement with the observation that purinergic sig-
naling is present and critical in switching on genes for
development of the nervous system and the eye of the
Xenopus around the time of gastrulation [67-69]. Ca2+
waves occur during early development, between stages 9
and 12 in the dorsal ectoderm of Xenopus [70]. From
stage 10 onwards, [Ca2+]i transients are limited to re-
gions of forebrain, midbrain and eyes overlapping with
the approximate location and time of ATP release
[69,71]. The relationship between P2 receptor and tran-
scription factor activation by ICS is well illustrated in
Figure 3.
Conclusions
ICS is an important issue to study because of its versatil-
ity, which controls different cell processes essential for
cellular function, including stem cell differentiation.
Much evidence points at an important physiological role
of extracellular ATP during neuronal development by
stimulating proliferation and/or differentiation of NSC
and progenitor cells depending on the repertoire of P2
receptor subtype expression. Agonists and antagonists
might provide novel and powerful tools for modulating
these cell functions for therapy of developmental
diseases and regeneration therapy in neurodegenerative
diseases. P2X and P2Y purinergic receptors promote
proliferation by a mechanism in which ATP induces
increases in [Ca2+]i in form of waves or spikes, leading
to activation of various effectors, followed by an alter-
ation in transcription factor expression and activity
patterns such as CREB, NFAT and MEF2, which are
involved in stimulation of neural gene transcription. Bet-
ter understanding of these processes will establish the
importance of purinergic signaling in stem cell biology.
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